About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Austin | 7,623 Studies Near You

Clinical TrialsAustin

Clinical Trials in Austin

Discover 7,623 clinical trials near Austin, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2121-2140 of 7,623 trials

CompletedCognoa ASD Diagnosis Aid Validation StudyThe primary objective of this study is to collect data to ascertain the Positive Predictive Value (PPV) and Negative Predictive Value (NPV) of the current version of the Cognoa…NCT04151290·Scottsdale, Arizona and 15 others CompletedTo Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes TherapiesThis was a 10-week, placebo-controlled, randomized study to investigate the effect of injectable IL-1B antagonist, Canakinumab , in participants with impaired glucose tolerance or…NCT01068860·Los Angeles, California and 51 others

Find Trials by Condition in Austin

Breast Cancerin Austin Lung Cancerin Austin Prostate Cancerin Austin Colorectal Cancerin Austin Melanomain Austin Leukemiain Austin Lymphomain Austin Pancreatic Cancerin Austin Ovarian Cancerin Austin Brain Cancerin Austin Diabetesin Austin

Data from ClinicalTrials.govTerms

CompletedA Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of AgeThe primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1010, and to evaluate relative vaccine efficacy (rVE) of mRNA-1010 versus an active…NCT06602024·Anniston, Alabama and 300 others

CompletedCognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)The main purpose of this study is to assess the ability of a repeated high-frequency site-based computerized cognitive assessment to evaluate the potential treatment effects of…NCT04730635·Long Beach, California and 9 others

RecruitingA Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)US, multicenter, cohort, open label observational study with primary data collection.NCT06192576·Chicago, Illinois and 5 others

TerminatedStudy Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease PatientsThis is a study to evaluate the efficacy and safety of multiple doses of bapineuzumab in patients with mild to moderate Alzheimer Disease.NCT00667810·Birmingham, Alabama and 345 others

CompletedSafety and Efficacy of the CarboClear Pedicle Screw SystemThe purpose of this trial is to demonstrate the safety and effectiveness of the CarboClear Pedicle Screw System, for skeletally mature DDD patients undergoing one level spinal…NCT02626624·Boston, Massachusetts and 7 others

CompletedStudy of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant PainOpen-Label, Safety Study to evaluate the long-term safety of Kadian NT (ALO-01) administered for up to 12 months.NCT00415597·Birmingham, Alabama and 57 others

CompletedProof of Concept Study to Access Superficial Basal Cell Carcinoma in AdultsThis is a Phase 2, Single-Arm, Open-Label, Single Center, Proof of Concept Study to Assess Efficacy and Safety of Tirbanibulin Ointment 1% in Adult Subjects with superficial basal…NCT05713760·Pflugerville, Texas

CompletedStudy to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye DiseaseThe purpose of this study is to assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of subcutaneous (SC) satralizumab, a recombinant, humanized anti-interleukin-6…NCT05987423·Beverly Hills, California and 45 others

Completed24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic ArthritisThe purpose of this study is to provide 24 - 52 week efficacy, safety and tolerability data, and up to 3-year efficacy, safety and tolerability data in subjects with active…NCT01989468·Aventura, Florida and 76 others

CompletedStudy of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has SpreadThe primary objective of this study is to assess overall survival (OS) with sacituzumab govitecan-hziy in comparison with treatment of physician's choice (TPC) in participants…NCT04527991·Phoenix, Arizona and 233 others

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple…NCT02465060·Birmingham, Alabama and 1409 others

CompletedA Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic DermatitisThis study will evaluate upadacitinib compared to dupilumab (Dupixent®) in adults with moderate to severe atopic dermatitis (AD) who are candidates for systemic therapy.NCT03738397·Birmingham, Alabama and 158 others

RecruitingSafety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder CancerTARA-002-101-Ph2 is an open-label study to investigate the safety and efficacy of intravesical instillation of TARA-002 in adults 18 years of age or older with high-grade CIS…NCT05951179·Homewood, Alabama and 77 others

TerminatedStudy of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyThis Phase 3 study will compare the efficacy of talabostat plus pemetrexed to pemetrexed plus placebo in patients with Stage IIIB/IV NSCLC who have failed a platinum-based…NCT00290017·Huntsville, Alabama and 100 others

CompletedA Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice DailyThe purpose of this trial is to assess the non-inferior antiviral activity of GSK1349572 50 mg once daily versus RAL 400mg twice daily over 48 weeks; non-inferiority will also be…NCT01227824·Phoenix, Arizona and 100 others

TerminatedSAINT for MDD in an Inpatient Setting Follow-onRandomized, multi-site, sham-controlled, double-blinded studyNCT06462820·Iowa City, Iowa and 3 others

CompletedA Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASHThis is a Phase 2 Study to evaluate the effect of DD01 treatment in overweight/obese patients with metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic…NCT06410924·Maitland, Florida and 11 others

CompletedBioequivalency Study of 7.5 mg Pilocarpine Tablets Under Fasting ConditionsThe objective of this study was the bioequivalence of a Roxane Laboratories' Pilocarpine tablets, 7.5 mg, to SALAGEN® Tablets, 7.5 mg (MGI) under fasting conditions using a…NCT00602524·Austin, Texas

PreviousPage 107 of 382Next

Heart Diseasein Austin